Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice.

by Fabrizio Grosjean, Elena M Yubero-Serrano, Feng Zheng, Vittoria Esposito, Shobha Swamy, Sharon J Elliot, Weijing Cai, Helen Vlassara, Fadi Salem, Gary E Striker
Published 2018-01-01